MIGRALIS 50 TAB is a high-quality pharmaceutical product containing Propranolol Hydrochloride 50 mg, a non-selective beta-adrenergic blocker widely used in the prophylaxis of migraines and treatment of several cardiovascular and neurological conditions. It functions by blocking the action of stress hormones like adrenaline on the beta receptors in the heart and blood vessels, which results in a reduction in heart rate, cardiac output, and blood pressure. This mechanism not only controls high blood pressure and angina but also helps to stabilize blood flow in the brain, thereby reducing the frequency and severity of migraine attacks.

As a preventive migraine medication, MIGRALIS 50 TAB is not intended for acute relief but rather for long-term management to reduce migraine episodes over time. It is also prescribed in clinical situations involving performance anxiety, essential tremors, arrhythmias, and hypertrophic subaortic stenosis. Its versatility makes it an essential drug in neurology and cardiology practice alike.

The usual adult dosage of MIGRALIS 50 TAB is one tablet per day or as directed by a physician, depending on the patient’s response and medical condition. Consistent use leads to better results, especially in migraine prophylaxis, where improvements are usually observed after several weeks of continuous therapy. The drug is generally well tolerated, although patients may experience side effects such as fatigue, cold extremities, or sleep disturbances, which should be monitored during long-term use.

MIGRALIS 50 TAB is manufactured by Bluepill Express in WHO-GMP certified facilities with a focus on product safety, therapeutic accuracy, and batch-to-batch consistency. The tablet is produced under strict quality control measures, and all production batches are supported with comprehensive regulatory documentation including COA, MSDS, stability data, and product dossiers for international market access. It is available in secure, moisture-resistant packaging formats such as alu-alu or blister packs, tailored to meet the specific labeling and registration requirements of various countries.

As a reliable solution for migraine prophylaxis and multiple cardiovascular disorders, MIGRALIS 50 TAB is widely suitable for hospitals, clinics, retail pharmacies, and export distributors operating in regulated and semi-regulated pharmaceutical markets. Its formulation ensures patient compliance, clinical effectiveness, and commercial viability under the trusted Bluepill Express brand.